Effects of various hypolipidemic drugs on fatty acid composition of liver and serum lipids. 1975

R Maier, and K Muller

1. Treatment of rats with hypolipidemic drugs elicited an increase in oleic and a decrease in linoleic acid content in cholesterol esters, triglycerides and phospholipids of serum and liver lipids. 2. The change was most pronounced in triglycerides followed by cholesterol esters and phospholipids. 3. The shift was dose-dependent, starting with doses eliciting hypolipidemic effects. 4. The shift became obvious immediately after beginning of treatment and reached after 4 days a new steady state. 5. This effect was shared by both drugs of aryloxy fatty acid structure, but was not seen with either L-thyroxine or nicotinic acid. 6. The mechanism underlying this phenomenon is thus far unknown, but in our view it merits further attention.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009255 Nafenopin A peroxisome proliferator that is used experimentally to promote liver tumors. It has been used as an antihyperlipoproteinemic agent. CH-13437,Melipan,Nafenoic Acid,SU-13,437,Acid, Nafenoic,CH 13437,CH13437,SU 13,437,SU13,437
D009539 Nicotinic Acids 2-, 3-, or 4-Pyridinecarboxylic acids. Pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position. The 3-carboxy derivative (NIACIN) is active as a vitamin. Acids, Nicotinic
D009829 Oleic Acids A group of fatty acids that contain 18 carbon atoms and a double bond at the omega 9 carbon. Octadecenoic Acids,Acids, Octadecenoic,Acids, Oleic
D010169 Palmitic Acids A group of 16-carbon fatty acids that contain no double bonds. Acids, Palmitic
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D002788 Cholesterol Esters Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis. Cholesterol Ester,Cholesteryl Ester,Cholesteryl Esters,Ester, Cholesterol,Ester, Cholesteryl,Esters, Cholesterol,Esters, Cholesteryl
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl

Related Publications

R Maier, and K Muller
February 1981, Rinsho byori. The Japanese journal of clinical pathology,
R Maier, and K Muller
January 1969, Sapporo igaku zasshi. The Sapporo medical journal,
R Maier, and K Muller
February 1974, Bollettino della Societa italiana di biologia sperimentale,
R Maier, and K Muller
February 1974, Bollettino della Societa italiana di biologia sperimentale,
R Maier, and K Muller
January 1984, Comparative biochemistry and physiology. B, Comparative biochemistry,
R Maier, and K Muller
May 1970, Journal of dairy science,
R Maier, and K Muller
January 1987, Voprosy meditsinskoi khimii,
R Maier, and K Muller
January 1970, Atherosclerosis,
R Maier, and K Muller
November 1992, The Clinical investigator,
Copied contents to your clipboard!